abstract |
Novel 1-(2-phenyl-2-hydroxyethylamino)-3-phenoxypropan-2-ols of the formula I are prepared by hydrolysis from an oxazolidinone or oxazolidine of the formulae IIa or IIb. The symbols in the formulae I, IIa and IIb have the meanings given in Patent Claim 1. The compounds of the formula I have a cardiovascular effect and in addition possess vasodilatory, antihypertensive and antiarrhythmic activity. <IMAGE> |